
Anavex Life Sciences Corp.
AVXL institutional ownership changes in Q2 2026: 58 institutions opened or added positions, 50 trimmed or exited. AVXL (Anavex Life Sciences Corp.) is held by 102 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($20.9M), Vanguard Capital Management LLC ($10.5M), Two Sigma Investments, LP ($7.9M). Net institutional sentiment: Mixed.
Who's Trading
Latest move
Source dates: Price Nov 5, 2026 · Insiders Sep 12, 2025 · Activists Jul 31, 2026 · Congress none
Top Holders
Showing 1-20 of 116
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about AVXL
Who owns AVXL?
102 institutional investors held AVXL on June 30, 2026, led by BlackRock, Inc. ($20.9M), Vanguard Capital Management LLC ($10.5M) and Two Sigma Investments, LP ($7.9M).
How many hedge funds hold AVXL?
102 institutional investors reported AVXL in their 13F filings for the quarter ended June 30, 2026, $88.7M in all. 6 of them are rated Elite.
Are institutions buying or selling AVXL?
Buying, on balance. In Q2 2026, 58 institutions opened or added to positions in AVXL and 50 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer